Cyphaira Corp.

What they do

The company generates revenue from administrative services, which increased in the recent quarter. It also incurs costs related to growing supplies for cannabis product, indicating involvement in cannabis cultivation. The filings do not describe the scale or nature of its operations beyond these points.

Revenue drivers

• Administrative services — Revenue increase in Q2 2022 was attributed to an increase in administrative service revenue, totaling $8,900 for the quarter.
• Cannabis growing supplies — Cost of goods sold of $12,791 in Q2 2022 was related to growing supplies for cannabis product, indicating this is a cost center rather than a revenue driver.

Recent performance

For the three months ended June 30, 2022, revenue was $8,900, up from $6,000 in the same period of 2021. Cost of goods sold was $12,791, leading to a gross loss. Selling, general and administrative expenses were $94,686, up from $66,711. Net loss widened to $102,091 from $59,800. For the six months ended June 30, 2022, revenue fell 26% to $11,900 and net loss was $202,050.

Strategy

The filing does not provide a clear stated strategy. The company appears to be expanding cannabis-related activities, as evidenced by new cost of goods sold for growing supplies. Management has not articulated specific investments or priorities beyond covering operating costs.

Risks

• Going concern risk — The company has sustained significant net losses and may lack sufficient cash to continue operations without additional financing.
• Revenue concentration — Revenue is minimal and primarily from administrative services, with no evidence of diversified or scaled commercial operations.
• Cost overruns — Cost of goods sold exceeds revenue in the quarter, resulting in negative gross margins.
• Cannabis regulatory risk — The company's involvement in cannabis growing supplies exposes it to evolving and uncertain federal and state regulations.

Outlook

Management does not provide specific guidance. The company expects to continue incurring costs for cannabis-related supplies. Future financing needs are likely, given the persistent losses and limited revenue base.